1S90 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Seres Therapeutics Inc

Watchlist Manager

Watchlist

Price: 1.862 EUR 3.44%

Market Cap: €16.9m

	Seres Therapeutics Inc F:1S90	US
C	China Meheco Group Co Ltd SSE:600056	CN

Profitability Summary

Seres Therapeutics Inc's profitability score is 7/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-4 154%

Negative 3Y Average Operating Margin

-10 645%

Declining Operating Margin

-55% > -4 154%

Negative Net Margin

-1 193%

Negative 3Y Average Net Margin

-618%

Declining Net Margin

-112% > -1 193%

Negative Free Cash Flow Margin

-2 724%

Negative 3Y Average Free Cash Flow Margin

-2 606%

Declining Free Cash Flow Margin

-106% > -2 724%

Negative ROE

-67%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-81%

Declining ROIC

-54% > -86%

View All

Hide

Collapse

7 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.